H2 Equity Partners is pleased to announce its investment in Lynch Medical Supplies (“LMS”) alongside founder, John Lynch and Managing Director, Robert Buckley.

Established in 2003, LMS has grown into one of Ireland’s leading specialist suppliers of orthopaedic surgical devices, implants and medical consumables across the island of Ireland, underpinned by exclusive relationships with leading global manufacturers and long-standing ties with public and private healthcare providers and pharmacies.

The executive team, led by Robert Buckley, will continue to lead the business and work closely with H2 and John Lynch to deliver LMS’ ambitious growth strategy and maintain its high standards of customer service.

As a specialist in founder-led or primary buy-out transactions, H2 Equity Partners has built a strong track record in healthcare, with LMS being its eighth founder-led platform in the sector including Healthcare 21, Optegra, MedHealth, amongst others over the past number of years.

About H2 Equity Partners

H2 Equity Partners is a leading independent investment firm, making investments in medium-sized companies with significant growth or improvement potential. The H2 team has built an exceptional track record of acquiring, strengthening and growing fundamentally attractive businesses. H2 invests in companies across all sectors that have strong market positions and competitive advantages, which can benefit from the extensive international operating experience of the H2 team.

H2 Equity Partners is currently investing from H2EP Fund VI and focuses on making investments in the United Kingdom and Ireland. LMS is the fourth new platform investment of 2026.